ORIC PHARMACEUTICALS INC (ORIC)

US68622P1093 - Common Stock

9.16  +0.14 (+1.55%)

After market: 9.16 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

 MRQ
(2024-3-31)		 2023
(2023-12-31)		 2022
(2022-12-31)		 2021
(2021-12-31)		 2020
(2020-12-31)
ASSETS
Current Assets
Cash Equivalents
56.36M23.38M66.80M226.00M78.40M
Marketable Securities
260.42M184.80M139.40M11.00M215.20M
Other Current Assets
7.30M4.41M4.20M3.50M3.10M
Total Current Assets
324.08M212.60M210.50M240.50M296.70M
 
Non-Current Assets
PPE Net
2.80M2.86M3.30M2.40M2.00M
Investments And Advances
14.69M26.85M22.00M43.40MN/A
Other Non-Current Assets
9.21M9.70M11.50M12.30M300.00K
Total Non-Current Assets
26.70M39.41M36.70M58.10M2.30M
 
TOTAL ASSETS
350.79M252.01M247.20M298.60M299.00M
 
LIABILITIES
Current Liabilities
Short Term Debt
0.000.000.000.000.00
Accrued Expenses
12.22M19.51M14.10M13.30M7.70M
Accounts Payable
2.99M944.00K1.30M1.90M800.00K
Other Current Liabilities
N/AN/AN/A0.00500.00K
Total Current Liabilities
15.21M20.46M15.40M15.20M9.00M
 
Non-Current Liabilities
Long Term Debt
0.000.000.000.000.00
Other Non-Current Liabilities
6.93M7.46M9.40M10.50M200.00K
Total Non-Current Liabilities
6.93M7.46M9.40M10.50M200.00K
 
TOTAL LIABILITIES
22.14M27.92M24.80M25.70M9.20M
 
SHAREHOLDERS' EQUITY
Retained Earnings
-460.10M-434.67M-335.50M-245.20M-166.40M
Additional Paid In Capital
788.74M658.75M557.90M518.20M456.20M
Common Shares
7.00K6.00K0.000.000.00
Shares Outstanding
67.42M54.87M45.10M39.40M36.70M
Tangible Book Value per Share
4.874.084.936.937.90
Total Shareholders' Equity
328.64M224.09M222.40M273.00M289.80M
 
TOTAL LIABILITIES AND EQUITY
350.79M252.01M247.20M298.60M299.00M
 
Statistics
Current Ratio
21.3110.3913.6715.8232.97
Return On Assets (ROA)
-29.01%-39.96%-36.05%-26.36%-24.65%
Return On Equity (ROE)
-30.96%-44.94%-40.07%-28.84%-25.43%

All data in USD

Charts